{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:47:41Z","timestamp":1782197261083,"version":"3.54.5"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gliomas are aggressive brain tumors with a dismal prognosis, and their development, progression, and responsiveness to treatment are all impacted by mismatch repair (MMR) deficiency. This work aimed to construct a predictive risk model based on MMR-related genes and confirm its clinical applicability, with a focus on identifying novel therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical and mRNA expression data from The Cancer Genome Atlas (TCGA) and The Chinese Glioma Genome Atlas (CGGA) glioma patients were analyzed. MMR-related genes were sourced from the Molecular Signatures Database (MSigDB). A risk score model was created using multivariate Cox regression and LASSO analysis. Patients were categorized into high- and low-risk groups based on the median risk score. The model\u2019s performance was assessed using ROC curves, AUC, and Kaplan-Meier survival analysis. Immune cell infiltration was quantified using \u201cCIBERSORT\u201d and \u201cQUANTISEQ\u201d. Immunotherapy potential was evaluated via TMB, TME, and TIDE scores. The half maximal inhibitory concentration (IC\n                      <jats:sub>50<\/jats:sub>\n                      ) analyses were performed.\n                      <jats:italic>In vitro<\/jats:italic>\n                      validation involved MCM8 overexpression\/knockdown in U251\/LN229 glioma cells, followed by TMZ sensitivity testing via CCK-8 assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      An eight-MMR-related gene prognostic model (HMGB1, MCM8, MUTYH, PMS1, RNASEH2B, RNASEH2C, RPA3, TP73) was constructed. The risk score was an independent prognostic factor, with high-risk patients showing significantly poorer overall survival. The validity of this model has been validated in the CGGA dataset. Significant differences in immune infiltration, TME, and TMB scores were observed between risk groups. Drug sensitivity analysis revealed distinct IC\n                      <jats:sub>50<\/jats:sub>\n                      profiles for chemotherapeutic agents between the groups. Most importantly,\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments demonstrated that MCM8 overexpression increased glioma cell sensitivity to TMZ, while MCM8 knockdown decreased it, identifying MCM8 as a potential target for TMZ-based personalized therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study establishes a robust MMR-related prognostic model for glioma that effectively stratifies patients, predicts survival, and reflects distinct immune microenvironments. Critically, we identify MCM8 as a novel and actionable biomarker that modulates TMZ sensitivity, offering a promising avenue for personalized treatment in glioma patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1652739","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:06:30Z","timestamp":1782194790000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of biomarkers related to mismatch repair for prognosis prediction in glioma"],"prefix":"10.3389","volume":"17","author":[{"given":"Jia","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, China"]},{"name":"Department of Pharmacy, Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankai","family":"Si","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Qingdao University Affiliated Women and Children\u2019s Hospital","place":["Qingdao, China"]},{"name":"Department of Pharmacy, Peking University People\u2019s Hospital Qingdao Hospital","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, China"]},{"name":"Department of Pharmacy, Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, China"]},{"name":"Department of Pharmacy, Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.606164","article-title":"Six immune associated genes construct prognostic model evaluate low-grade glioma","volume":"11","author":"Qiu","year":"2020","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.20944\/preprints202401.1989.v1","article-title":"Cancer treatments: Past, present, and future","author":"Sonkin","year":"2024","journal-title":"Cancer Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.66114","article-title":"CircCDK14 promotes tumor progression and resists ferroptosis in glioma by regulating PDGFRA","volume":"18","author":"Simin","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-022-03008-6","article-title":"2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist","volume":"64","author":"McNamara","year":"2022","journal-title":"Neuroradiology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/JCMM.16221","article-title":"Expression and prognostic characteristics of m5C regulators in low\u2010grade glioma","volume":"25","author":"Xiaozhi","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1488894","article-title":"Development and experimental validation of dephosphorylation-related biomarkers to assess prognosis and immunotherapeutic response in gliomas","volume":"15","author":"Tang","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1021\/cr0404794","article-title":"DNA mismatch repair: functions and mechanisms","volume":"106","author":"Iyer","year":"2006","journal-title":"Chem Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/cr.2007.115","article-title":"Mechanisms and functions of DNA mismatch repair","volume":"18","author":"Li","year":"2008","journal-title":"Cell Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23015","article-title":"Mismatch repair deficiency: The what, how and why it is important","volume":"61","author":"Olave","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3918\u20133918","DOI":"10.3390\/cancers16233918","article-title":"Advances in immunotherapy for endometrial cancer: Insights into MMR status and tumor microenvironment","volume":"16","author":"Valls","year":"2024","journal-title":"Cancers"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10513","article-title":"Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status","volume":"18","author":"Maria","year":"2019","journal-title":"Oncol Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.17","article-title":"Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment","volume":"114","author":"Park","year":"2016","journal-title":"Br J Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-0121","article-title":"A subset of localized prostate cancer displays an immunogenic phenotype associated with losses of key tumor suppressor genes","volume":"27","author":"Calagua","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13857","article-title":"Microsatellite instability and survival in stage II colorectal cancer: A systematic review and meta-analysis","volume":"39","author":"Petrelli","year":"2019","journal-title":"Anticancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.07.020","article-title":"Deficient mismatch repair\/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment","volume":"175","author":"Taieb","year":"2022","journal-title":"Eur J Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6716\u20136716","DOI":"10.3390\/ijms21186716","article-title":"Mismatch-repair protein expression in high-grade gliomas: A large retrospective multicenter study","volume":"21","author":"Mario","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00401-020-02243-6","article-title":"Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis","volume":"141","author":"Suwala","year":"2020","journal-title":"Acta Neuropathol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12076","article-title":"Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-\u03b2 signaling","volume":"6","author":"Yao","year":"2016","journal-title":"FEBS Open Bio"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S226804","article-title":"Apatinib plus temozolomide for recurrent glioblastoma: An uncontrolled, open-label study","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.Cancergen.2025.08.010","article-title":"Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration","author":"Ubaid","year":"2025","journal-title":"Cancer Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70\u201370","DOI":"10.1186\/s40364-024-00620-x","article-title":"Voltage-gated sodium channels in cancers","volume":"12","author":"Liu","year":"2024","journal-title":"biomark Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"162\u2013162","DOI":"10.1007\/s10142-024-01443-7","article-title":"Is the voltage-gated sodium channel \u03b23 subunit (SCN3B) a biomarker for glioma","volume":"24","author":"Liu","year":"2024","journal-title":"Funct Integr Genomics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.Bbadis.2025.167844","article-title":"The voltage-gated sodium channel \u03b23 subunit modulates C6 glioma cell motility independently of channel activity","volume":"1871","author":"Liu","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msy134","article-title":"Specificity of the DNA mismatch repair system (MMR) and mutagenesis bias in bacteria","volume":"35","author":"Long","year":"2018","journal-title":"Mol Biol Evol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-14-0332","article-title":"Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies","volume":"20","author":"Sabine","year":"2014","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01888-1","article-title":"MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1004324","article-title":"MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11010084","article-title":"MUTYH as an emerging predictive biomarker in ovarian cancer","volume":"11","author":"Hutchcraft","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155559","article-title":"Comprehensive exploration on the role of base excision repair genes in modulating immune infiltration in low-grade glioma","volume":"262","author":"P","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2023.69.5.14","article-title":"RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-AKT-mTOR pathway","volume":"69","author":"Liang","year":"2023","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41419-019-1477-5","article-title":"The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells","volume":"10","author":"Mazor","year":"2019","journal-title":"Cell Death Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4016","article-title":"Integrative analysis of TP73 profile prognostic significance in WHO grade II\/III glioma","volume":"10","author":"Chen","year":"2021","journal-title":"Cancer Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.12659\/msm.912104","article-title":"High mobility group box 1 (HMGB1) predicts invasion and poor prognosis of glioblastoma multiforme via activating AKT signaling in an autocrine pathway","volume":"24","author":"Cheng","year":"2018","journal-title":"Med Sci Monit"},{"key":"B37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ng0398-276","article-title":"Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair","volume":"18","author":"Prolla","year":"1998","journal-title":"Nat Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0960327114532386","article-title":"Identification of novel genes involved in gastric carcinogenesis by suppression subtractive hybridization","volume":"34","author":"Mottaghi-Dastjerdi","year":"2015","journal-title":"Hum Exp Toxicol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1159\/000452281","article-title":"DNA-sensing and nuclease gene expressions as markers for colorectal cancer progression","volume":"92","author":"Yang","year":"2017","journal-title":"Oncology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2018.09.047","article-title":"Epithelial RNase H2 maintains genome integrity and prevents intestinal tumorigenesis in mice","volume":"156","author":"Aden","year":"2019","journal-title":"Gastroenterology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1774-y","article-title":"Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis","volume":"134","author":"Beyer","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10555-021-09997-9","article-title":"Glioma: molecular signature and crossroads with tumor microenvironment","volume":"41","author":"Barthel","year":"2022","journal-title":"Cancer Metastasis Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.Cancergen.2025.03.004","article-title":"Identification of new immune target and signaling for cancer immunotherapy","author":"Narote","year":"2025","journal-title":"Cancer Genet"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.11.009","article-title":"Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy","volume":"99","author":"Komohara","year":"2016","journal-title":"Adv Drug Delivery Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.08.019","article-title":"The molecular feature of macrophages in tumor immune microenvironment of glioma patients","volume":"19","author":"Zhang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ccell.2024.12.006","article-title":"Infiltrating plasma cells maintain glioblastoma stem cells through IgG-tumor binding","volume":"43","author":"Gao","year":"2024","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac291","article-title":"Immune infiltration and clinical significance analyses of the coagulation-related genes in hepatocellular carcinoma","volume":"23","author":"He","year":"2022","journal-title":"Brief Bioinform"},{"key":"B51","doi-asserted-by":"publisher","first-page":"148449\u2013148449","DOI":"10.1016\/j.Gene.2024.148449","article-title":"A novel cancer-germline gene DAZL promotes progression and cisplatin resistance of non-small cell lung cancer by upregulating JAK2 and MCM8","volume":"916","author":"Zhou","year":"2024","journal-title":"Gene"},{"key":"B52","doi-asserted-by":"publisher","first-page":"102042\u2013102042","DOI":"10.1016\/j.Genrep.2024.102042","article-title":"Genetic expression in cancer research: Challenges and complexity","volume":"37","author":"Liu","year":"2024","journal-title":"Gene Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","article-title":"Technical and biological biases in bulk transcriptomic data mining for cancer research","volume":"16","author":"Liu","year":"2025","journal-title":"J Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1652739\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:06:31Z","timestamp":1782194791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1652739\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2026.1652739"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1652739","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"article-number":"1652739"}}